China SXT Pharmaceuticals (SXTC) Accumulated Expenses (2018 - 2026)
China SXT Pharmaceuticals' Accumulated Expenses was $3.3 million in fiscal Q4 2026 (quarter ended Mar 31, 2026), up 12.5% from $2.94 million a year earlier.
Powered by 
Analysis
China SXT Pharmaceuticals (SXTC) Accumulated Expenses (2018 - 2026) Analysis & Trends
From fiscal Q4 2018 onward, China SXT Pharmaceuticals has reported Accumulated Expenses for 16 quarters.
- Accumulated Expenses shows a five-year compound annual growth rate of 1.6% (FY2021 to FY2026).
- In earlier fiscal years, Accumulated Expenses was $2.94 million in FY2025 (+6.1%), $2.77 million in FY2024 (-11.9%), $3.14 million in FY2023 (-11.0%) and $3.53 million in FY2022 (+15.8%).
- The fiscal Q4 2026 figure marks the highest quarterly Accumulated Expenses since fiscal Q4 2022.
- Compared with a year earlier, Accumulated Expenses was higher in three of the last four quarters, with growth averaging 5.1%.
- The best year-over-year quarter for Accumulated Expenses over five years was fiscal Q4 2022 (growth of 15.8%); the worst was fiscal Q4 2024 (a decline of 11.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | China SXT Pharmaceuticals | 345.60 | -85.95 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3.30 Mn |
| Sep 30, 2025 | 3.27 Mn |
| Mar 31, 2025 | 2.94 Mn |
| Sep 30, 2024 | 2.92 Mn |
| Mar 31, 2024 | 2.77 Mn |
| Sep 30, 2023 | 3.25 Mn |
| Mar 31, 2023 | 3.14 Mn |
| Sep 30, 2022 | 3.28 Mn |
| Mar 31, 2022 | 3.53 Mn |
| Sep 30, 2021 | 3.36 Mn |
| Mar 31, 2021 | 3.05 Mn |
| Sep 30, 2020 | 2.46 Mn |
| Mar 31, 2020 | 2.24 Mn |
| Sep 30, 2019 | 701,876.00 |
| Mar 31, 2019 | 691,522.00 |
| Sep 30, 2018 | 314,371.00 |
| Mar 31, 2018 | 416,226.00 |
API Access
China SXT Pharmaceuticals Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=SXTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "SXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=SXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();